Verify Mechanisms Across the Global Research Landscape
Ensure your target or mechanism is supported by independent, cross-institutional evidence before advancing programs or defending strategic decisions.
The Gap in Current Workflows
Internal teams, molecular models, and AI predictions cannot independently verify mechanisms across competing evidence.
- Internal insights are siloed; molecular simulations assume ideal conditions.
- Consultants or CROs rarely integrate cross-program or global signals.
- Literature reviews miss ongoing parallel investigations and unpublished directional trends.
Internal data shows intent. Independent validation shows truth.
Why Independent Validation Matters
Validate whether a proposed mechanism truly holds across datasets, hypotheses, and real-world evidence.
- Identify gaps or conflicting results invisible to single programs.
- Quantify relative strength of evidence and directional trends.
- Reduce risk for board decisions, repurposing pivots, or indication expansions.
The Reasoning Layer
Cross-institutional data, hypothesis infrastructure, and global knowledge signals are integrated without revealing individual sources.
- Provides a standardized, formalized evidence layer across competing mechanisms and programs.
- Converts independent signals into actionable insights for executives and governance committees.
- Reports allow direct comparison across competing mechanisms or programs.
How It Works
Commission your mechanism validation when your program's decision point approaches.
- Describe your mechanism and program context.
- Skygenic scopes the engagement to your needs.
- Structured report provides quantitative scoring, trend mapping, and global context.
Related reports
Explore adjacent validation types within your decision workflow.
View all Pharma validation reports for the full cluster overview and internal navigation.
Strategic Audit
Request a mechanism validation report
Independent mechanism verification for pharmaceutical programs. Cross-institutional analysis for programs approaching critical decision points.